UNION CITY, Calif., Sept. 8, 2017 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, announced today that Ross Taylor, Chief Financial Officer, will present at the following investor conferences:

  • Morgan Stanley 15 Annual Global Healthcare Conference on Wednesday, September 13, 2017 at 11:40 a.m. ET. The conference will be held at the Grand Hyatt New York Hotel in New York City.
  • CL King 15 Annual Best Ideas Conference 2017 on Thursday, September 14, 2017 at 12:30 p.m. ET. The conference will be held at the Omni Berkshire Palace Hotel in New York City.

About Abaxis

Abaxis, Inc. is a worldwide developer, manufacturer and marketer of portable blood analysis systems that are used in a broad range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements. Our mission is to improve the efficiency of care delivery to and the quality of life of patients in the medical and veterinary markets. We provide leading edge technology and tools that support best medical practices, enabling physicians and veterinarians to respond to the health needs of their clients at the point of care while operating economical and profitable practices. For more information, visit http://www.abaxis.com.

Contact:

Clint Severson

Lytham Partners, LLC

Chief Executive Officer

Joe Dorame, Joe Diaz & Robert Blum

ABAXIS, Inc.

602-889-9700

510-675-6500

View original content:http://www.prnewswire.com/news-releases/abaxis-inc-to-present-at-the-morgan-stanley-15th-annual-global-healthcare-conference-and-the-cl-king-15th-annual-best-ideas-conference-2017-300516509.html

SOURCE Abaxis, Inc.

ABAXIS Inc. published this content on 08 September 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 08 September 2017 20:13:09 UTC.

Original documenthttp://phx.corporate-ir.net/phoenix.zhtml?c=115152&p=irol-newsArticle&ID=2299522

Public permalinkhttp://www.publicnow.com/view/C388A0A6DC7E1F52CFF3980B7DA8D651B4DE6A02